Myeloproliferative leukemia protein activation directly induces fibrocyte differentiation to cause myelofibrosis

T Maekawa1, Y Osawa1, T Izumi1

  • 1Division of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.

Leukemia
|April 8, 2017
PubMed

Insights

Fibrocytes contribute to myelofibrosis (MF) progression by differentiating through the thrombopoietin (TPO)/MPL signaling pathway. Targeting this pathway may offer new therapeutic strategies for MF.

Area of Science:

  • Hematology
  • Oncology
  • Cell Biology

Background:

  • Myelofibrosis (MF) pathogenesis involves complex mechanisms including cytokines, cellular interactions, and genetic mutations, but remains incompletely understood.
  • Fibrocytes, a type of hematopoietic cell, and the thrombopoietin (TPO)/myeloproliferative leukemia protein (MPL) signaling pathway are implicated in MF development.

Purpose of the Study:

  • To investigate the direct relationship between fibrocytes and MPL activation in the context of myelofibrosis.

Main Methods:

  • Utilized murine fibrocyte cell lines and a murine MF model to assess TPO or TPO receptor agonist effects on fibrocyte differentiation.
  • Employed clodronate liposomes to eliminate MPL-expressing macrophages and observed the impact on the MF phenotype.
  • Analyzed human peripheral blood mononuclear cells, specifically SLAMF7high MPLhigh monocytes, for fibrocyte precursor identification in MF patients.

Main Results:

  • TPO or its agonist directly induced fibrocyte differentiation in both cell lines and a murine MF model.
  • Eliminating MPL-expressing macrophages reversed the MF phenotype, indicating fibrocyte differentiation via MPL activation contributes to MF progression.
  • SLAMF7high MPLhigh monocytes were identified as potential fibrocyte precursors, with increased numbers observed in MF patients not receiving ruxolitinib.

Conclusions:

  • Established a direct link between fibrocytes and the TPO/MPL signaling pathway in MF pathogenesis.
  • Findings suggest that fibrocyte differentiation driven by MPL activation is a key factor in MF progression.
  • Identified specific monocyte populations as potential therapeutic targets for novel MF interventions.

Related Concept Videos

Mechanism of Filopodia Formation01:39

Mechanism of Filopodia Formation

Filopodia are thin, actin-rich cellular protrusions that play an important role in many fundamental cellular functions. They vary in their occurrence, length, and positioning in different cell types, suggesting their diverse roles.
Their main function is to guide migrating cells during normal tissue morphogenesis or cancer metastasis by recognizing and making initial contacts with the extracellular matrix. However, they can also act as stationary cell anchors or help to establish communication...
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...